Mice were treated daily with the covalent legumain inhibitor LI‐1, which is an analogue of SD‐134 that is acetylated instead of Cbz‐capped (Lee & Bogyo, 2012) or DMSO vehicle during colitis induction with DSS. The gene discussed is LGMN; the disease is colitis.